Shrier Wealth Management LLC Buys New Position in Merck & Co., Inc. $MRK

robot
Abstract generation in progress

Shrier Wealth Management LLC has acquired a new stake of 22,127 shares in Merck & Co., Inc. during the fourth quarter, valued at approximately $2.33 million, contributing to the 76.07% institutional ownership of the stock. This comes amidst several positive developments for Merck, including new pipeline collaborations, promising Phase 3 trial results for a cholesterol drug, and strong analyst sentiment with a consensus price target of $127.13. Despite some insider selling, the company maintains robust fundamentals, including a market cap of $297.3 billion and a quarterly dividend of $0.85.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin